Platform Expansion - Animal Health

About Alveo Technologies

Alveo Technologies is pioneering a decentralized molecular diagnostics platform centered on a palm-sized analyzer that delivers results in under an hour directly to a smartphone. Initially targeting the high-impact problem of Avian Influenza in poultry, the platform is designed for broad application across animal health, agriculture, food safety, and human healthcare. By moving accurate, multiplexed molecular testing out of central labs and into the field, Alveo seeks to enable faster outbreak containment, reduce economic losses, and improve bio-surveillance. The company, founded in 2016, is a private entity leveraging partnerships to validate and deploy its technology.

Therapeutic Areas